VRTX Chart
- 52-Week Range: $177.01 - $290.93
- Market Capitalization: $66.14B
- Short Percentage: 0%
- Target Price: $293.15
- Shares Outstanding: 255.76M
- Next Earnings: Jan 31
Catalysts
CategoryCatalyst
Earnings
VRTX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Vertex Announces $50 Million Commitment to Health Equity With Three Initial GrantsBusiness Wire | May 17th
- Is Vertex Pharmaceuticals' Billion-Dollar Business Getting Even Bigger?The Motley Fool | May 9th
- Vertex: Q1 Results Solid, If Unspectacular, But Pipeline Progress Makes Bull CaseSeeking Alpha | May 6th
- This Stock Is Trouncing the Market in 2022 -- and Its Prospects Just Got Even BetterThe Motley Fool | May 5th
Company Info
Website: https://www.vrtx.com
Address: 50 Northern Avenue, Boston, MA, United States, 02210
Sector: Healthcare
Industry: Biotechnology
Full time employees: 3,900
Address: 50 Northern Avenue, Boston, MA, United States, 02210
Sector: Healthcare
Industry: Biotechnology
Full time employees: 3,900
$VRTX Games being played here.
$VRTX good support.....
$VRTX Nope
$VRTX great sale!!!! Buy buy buy
$VRTX TRUST THE PROCESS! BUY AND HOLD! OUR TIME IS COMING$$$
$VRTX LFFGG
$VRTX Hold on to your Butts.
$VRTX who here can't stand the CEO?
$VRTX Buy now
$VRTX To the moon!!